Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Association between clozapine response and allelic variation in the 5-HT2C receptor gene.

Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, Price J, Collier DA, Kerwin RW.

Neuroreport. 1995 Dec 29;7(1):169-72.

PMID:
8742444
2.

Clozapine response and the 5HT2C Cys23Ser polymorphism.

Malhotra AK, Goldman D, Ozaki N, Rooney W, Clifton A, Buchanan RW, Breier A, Pickar D.

Neuroreport. 1996 Sep 2;7(13):2100-2.

PMID:
8930967
3.

Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor.

Rietschel M, Naber D, Fimmers R, Möller HJ, Propping P, Nöthen MM.

Neuroreport. 1997 May 27;8(8):1999-2003.

PMID:
9223092
4.

No evidence for association of serotonin-2A receptor variant (102T/C) with schizophrenia or clozapine response in a Chinese population.

Lin CH, Tsai SJ, Yu YW, Song HL, Tu PC, Sim CB, Hsu CP, Yang KH, Hong CJ.

Neuroreport. 1999 Jan 18;10(1):57-60.

PMID:
10094133
5.

Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine.

Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M, Roberts G, Price J, Kerwin RW.

Neurosci Lett. 1996 Oct 18;217(2-3):177-8.

PMID:
8916101
6.

Evidence for association between polymorphisms in the promoter and coding regions of the 5-HT2A receptor gene and response to clozapine.

Arranz MJ, Munro J, Owen MJ, Spurlock G, Sham PC, Zhao J, Kirov G, Collier DA, Kerwin RW.

Mol Psychiatry. 1998 Jan;3(1):61-6.

PMID:
9491814
7.

Serotonin-6 receptor variant (C267T) and clinical response to clozapine.

Yu YW, Tsai SJ, Lin CH, Hsu CP, Yang KH, Hong CJ.

Neuroreport. 1999 Apr 26;10(6):1231-3.

PMID:
10363930
8.

Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response.

Birkett JT, Arranz MJ, Munro J, Osbourn S, Kerwin RW, Collier DA.

Neuroreport. 2000 Jun 26;11(9):2017-20.

PMID:
10884063
9.

Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia.

Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vallada H, Smith I, Gill M, Kerwin RW.

Hum Genet. 1996 Jun;97(6):714-9.

PMID:
8641685
10.

Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine.

Rao PA, Pickar D, Gejman PV, Ram A, Gershon ES, Gelernter J.

Arch Gen Psychiatry. 1994 Nov;51(11):912-7.

PMID:
7944879
11.

Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility.

Segman RH, Heresco-Levy U, Finkel B, Inbar R, Neeman T, Schlafman M, Dorevitch A, Yakir A, Lerner A, Goltser T, Shelevoy A, Lerer B.

Psychopharmacology (Berl). 2000 Nov;152(4):408-13.

PMID:
11140333
12.

The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.

Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH, Breier A, Pickar D.

Mol Psychiatry. 1998 Jan;3(1):72-5.

PMID:
9491816
13.

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations.

Hwang R, Shinkai T, De Luca V, Müller DJ, Ni X, Macciardi F, Potkin S, Lieberman JA, Meltzer HY, Kennedy JL.

Psychopharmacology (Berl). 2005 Aug;181(1):179-87. Epub 2005 Oct 15.

PMID:
15830237
14.

Human genetic variations in the 5HT2A receptor: a single nucleotide polymorphism identified with altered response to clozapine.

Harvey L, Reid RE, Ma C, Knight PJ, Pfeifer TA, Grigliatti TA.

Pharmacogenetics. 2003 Feb;13(2):107-18.

PMID:
12563180
15.

Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients.

Barlas IO, Cetin M, Erdal ME, Semiz UB, Basoglu C, Ay ME, Herken H, Uzun O.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):56-60. doi: 10.1002/ajmg.b.30770.

PMID:
18449897
16.

Influence of serotonin 3A and 3B receptor genes on clozapine treatment response in schizophrenia.

Souza RP, de Luca V, Meltzer HY, Lieberman JA, Kennedy JL.

Pharmacogenet Genomics. 2010 Apr;20(4):274-6. doi: 10.1097/FPC.0b013e328337ce3e.

PMID:
20168265
17.

Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients.

Scharfetter J, Chaudhry HR, Hornik K, Fuchs K, Sieghart W, Kasper S, Aschauer HN.

Eur Neuropsychopharmacol. 1999 Dec;10(1):17-20.

PMID:
10647091
18.

Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects.

Kohn Y, Ebstein RP, Heresco-Levy U, Shapira B, Nemanov L, Gritsenko I, Avnon M, Lerer B.

Eur Neuropsychopharmacol. 1997 Feb;7(1):39-43.

PMID:
9088883
19.

Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response.

Arranz MJ, Li T, Munro J, Liu X, Murray R, Collier DA, Kerwin RW.

Pharmacogenetics. 1998 Dec;8(6):481-4.

PMID:
9918131
20.

Association between clozapine response and allelic variation in 5-HT2A receptor gene.

Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R.

Lancet. 1995 Jul 29;346(8970):281-2.

PMID:
7630250
Items per page

Supplemental Content

Write to the Help Desk